Dehm SM - Search Results

1

Methods for Identifying and Quantifying mRNA Expression of Androgen Receptor Splicing Variants in Prostate Cancer.

Li Y, Dehm SM. Li Y, et al. Among authors: dehm sm. Methods Mol Biol. 2016;1443:165-77. doi: 10.1007/978-1-4939-3724-0_11. Methods Mol Biol. 2016. PMID: 27246340

2

Regulation of androgen receptor signaling in prostate cancer.

Dehm SM, Tindall DJ. Dehm SM, et al. Expert Rev Anticancer Ther. 2005 Feb;5(1):63-74. doi: 10.1586/14737140.5.1.63. Expert Rev Anticancer Ther. 2005. PMID: 15757439 Review.

3

p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6.

Debes JD, Comuzzi B, Schmidt LJ, Dehm SM, Culig Z, Tindall DJ. Debes JD, et al. Among authors: dehm sm. Cancer Res. 2005 Jul 1;65(13):5965-73. doi: 10.1158/0008-5472.CAN-04-2837. Cancer Res. 2005. PMID: 15994976

4

Molecular regulation of androgen action in prostate cancer.

Dehm SM, Tindall DJ. Dehm SM, et al. J Cell Biochem. 2006 Oct 1;99(2):333-44. doi: 10.1002/jcb.20794. J Cell Biochem. 2006. PMID: 16518832 Review.

5

Androgen receptor structural and functional elements: role and regulation in prostate cancer.

Dehm SM, Tindall DJ. Dehm SM, et al. Mol Endocrinol. 2007 Dec;21(12):2855-63. doi: 10.1210/me.2007-0223. Epub 2007 Jul 17. Mol Endocrinol. 2007. PMID: 17636035 Review.

6

Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells.

Dehm SM, Regan KM, Schmidt LJ, Tindall DJ. Dehm SM, et al. Cancer Res. 2007 Oct 15;67(20):10067-77. doi: 10.1158/0008-5472.CAN-07-1267. Cancer Res. 2007. PMID: 17942941

7

Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.

Heemers HV, Regan KM, Dehm SM, Tindall DJ. Heemers HV, et al. Among authors: dehm sm. Cancer Res. 2007 Nov 1;67(21):10592-9. doi: 10.1158/0008-5472.CAN-07-1917. Cancer Res. 2007. PMID: 17975004

8

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.

Dehm SM, Schmidt LJ, Heemers HV, Vessella RL, Tindall DJ. Dehm SM, et al. Cancer Res. 2008 Jul 1;68(13):5469-77. doi: 10.1158/0008-5472.CAN-08-0594. Cancer Res. 2008. PMID: 18593950 Free PMC article.

9

Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis.

Raclaw KA, Heemers HV, Kidd EM, Dehm SM, Tindall DJ. Raclaw KA, et al. Among authors: dehm sm. Prostate. 2008 Nov 1;68(15):1696-706. doi: 10.1002/pros.20844. Prostate. 2008. PMID: 18726983 Free PMC article.

10

Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression.

Li Y, Alsagabi M, Fan D, Bova GS, Tewfik AH, Dehm SM. Li Y, et al. Among authors: dehm sm. Cancer Res. 2011 Mar 15;71(6):2108-17. doi: 10.1158/0008-5472.CAN-10-1998. Epub 2011 Jan 19. Cancer Res. 2011. PMID: 21248069 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters